Literature DB >> 25996118

Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes.

Scott Poh1,2, Venkatesh Chelvam1,3, Philip S Low1.   

Abstract

AIM: The vast majority of nanomedicine research is focused on the use of nanoparticles for the diagnosis and treatment of cancer. However, the dense extracellular matrix of solid tumors restricts nanoparticle penetration, raising the question of whether the best applications of nanomedicines lie in oncology. MATERIALS &
METHODS: In this study, the uptake of folate-conjugated liposomes was compared between folate receptor-expressing tumors and folate receptor+ inflammatory lesions within the same mouse.
RESULTS: We demonstrate here that both folate-targeted and nontargeted liposomes accumulate more readily at sites of inflammation than in solid tumors.
CONCLUSION: These data suggest that nanosized imaging and therapeutic agents may be better suited for the treatment and diagnosis of inflammatory/autoimmune diseases than cancer.

Entities:  

Keywords:  cancer; folate; inflammation; liposome; nanomedicine; nanoparticle

Mesh:

Substances:

Year:  2015        PMID: 25996118      PMCID: PMC4910969          DOI: 10.2217/nnm.14.237

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  45 in total

1.  Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.

Authors:  Mary Jo Turk; Joseph A Reddy; Jean A Chmielewski; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2002-02-10

Review 2.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

3.  The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro.

Authors:  Jacques Grill; Martine L M Lamfers; Victor W van Beusechem; Clemens M Dirven; D Shareen Pherai; Mathijs Kater; Paul Van der Valk; Ronald Vogels; W Peter Vandertop; Herbert M Pinedo; David T Curiel; Winald R Gerritsen
Journal:  Mol Ther       Date:  2002-11       Impact factor: 11.454

4.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

Authors:  Thommey P Thomas; Sascha N Goonewardena; Istvan J Majoros; Alina Kotlyar; Zhengyi Cao; Pascale R Leroueil; James R Baker
Journal:  Arthritis Rheum       Date:  2011-09

5.  Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque.

Authors:  Nynke A Jager; Johanna Westra; Reza Golestani; Gooitzen M van Dam; Philip S Low; René A Tio; Riemer H J A Slart; Hendrikus H Boersma; Marc Bijl; Clark J Zeebregts
Journal:  J Nucl Med       Date:  2014-10-30       Impact factor: 10.057

6.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors:  Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal:  Anal Biochem       Date:  2005-03-15       Impact factor: 3.365

7.  Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.

Authors:  Mary Jo Turk; Gert J Breur; William R Widmer; Chrystal M Paulos; Le-Cun Xu; Lee Ann Grote; Philip S Low
Journal:  Arthritis Rheum       Date:  2002-07

8.  A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.

Authors:  Wei Xia; Andrew R Hilgenbrink; Eric L Matteson; Michael B Lockwood; Ji-Xin Cheng; Philip S Low
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

Review 9.  VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

Authors:  Elizabeth R Gerstner; Dan G Duda; Emmanuelle di Tomaso; Peter A Ryg; Jay S Loeffler; A Gregory Sorensen; Percy Ivy; Rakesh K Jain; Tracy T Batchelor
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

10.  Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque.

Authors:  Nynke A Jager; Johanna Westra; Gooitzen M van Dam; Nato Teteloshvili; René A Tio; Jan-Cees Breek; Riemer H J A Slart; Hendrikus Boersma; Phillip S Low; Marc Bijl; Clark J Zeebregts
Journal:  J Nucl Med       Date:  2012-06-29       Impact factor: 10.057

View more
  8 in total

1.  Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Authors:  Mohiuddin A Quadir; Stephen W Morton; Lawrence B Mensah; Kevin Shopsowitz; Jeroen Dobbelaar; Nicole Effenberger; Paula T Hammond
Journal:  Nanomedicine       Date:  2017-03-02       Impact factor: 5.307

2.  Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts.

Authors:  Esben Christensen; Jonas R Henriksen; Jesper T Jørgensen; Yasmine Amitay; Hilary Shmeeda; Alberto A Gabizon; Andreas Kjær; Thomas L Andresen; Anders E Hansen
Journal:  Int J Nanomedicine       Date:  2018-11-19

3.  Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis.

Authors:  Gert-Jan Wijnant; Katrien Van Bocxlaer; Vanessa Yardley; Andy Harris; Mo Alavijeh; Rita Silva-Pedrosa; Sandra Antunes; Isabel Mauricio; Sudaxshina Murdan; Simon L Croft
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-12       Impact factor: 4.077

4.  Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy.

Authors:  Fei Hao; Robert J Lee; Lihuang Zhong; Shiyan Dong; Chunmiao Yang; Lirong Teng; Qingfan Meng; Jiahui Lu; Jing Xie; Lesheng Teng
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

5.  Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.

Authors:  F Bootz; D Venetz; B Ziffels; D Neri
Journal:  Protein Eng Des Sel       Date:  2016-08-11       Impact factor: 1.650

6.  The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices.

Authors:  Dimakatso Alice Senthebane; Tina Jonker; Arielle Rowe; Nicholas Ekow Thomford; Daniella Munro; Collet Dandara; Ambroise Wonkam; Dhirendra Govender; Bridget Calder; Nelson C Soares; Jonathan M Blackburn; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

7.  Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B.

Authors:  Gert-Jan Wijnant; Katrien Van Bocxlaer; Amanda Fortes Francisco; Vanessa Yardley; Andy Harris; Mo Alavijeh; Sudaxshina Murdan; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

8.  Functionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core.

Authors:  Xia Li; Manpreet Sambi; Alexandria DeCarlo; Sergey V Burov; Roman Akasov; Elena Markvicheva; Cecile Malardier-Jugroot; Myron R Szewczuk
Journal:  Nanomaterials (Basel)       Date:  2018-08-02       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.